Organogenesis Holdings ORGOW 深 沪

Small-cap healthcare stocks ranked by quant ratings after earnings season

As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factor...

05-26 22:20

Deckers Outdoor, UP Fintech And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures rise with Dow gaining 300 points. Deckers Outdoor Corp shares fall after beating Q4 revenue estimates and providing fiscal 2027 guidance.

05-22 20:38

Organogenesis Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY26 sales guidance below estimates.

Organogenesis Holdings shares are trading lower after the company reported wors...

05-08 19:59

What's Going On With Organogenesis Stock On Wednesday?

Organogenesis stock rises after PuraPly AM trial shows improved diabetic foot ulcer closure; RSI signals oversold levels amid weak trend.

04-08 22:15

Organogenesis Holdings Completes Type-B Meeting With FDA And Plans to File BLA For ReNu Before The End Of December

Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports

04-07 05:37

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

04-06 23:02

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

04-06 21:30

BTIG Reiterates Buy on Organogenesis Holdings, Maintains $8 Price Target

BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $8 price target.

03-26 17:43

Organogenesis Director Arthur S Leibowitz Acquires Common Shares

Organogenesis Director Arthur S Leibowitz Acquires Common Shares Arthur S. Leibowitz, a director of Organogenesis Holdings Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technolo

03-12 09:46

BTIG Maintains Buy on Organogenesis Holdings, Lowers Price Target to $8

BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and lowers the price target from $9 to $8.

02-27 18:35